Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma

NCT04397679 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped slow accrual

Conditions

Glioblastoma
Gliosarcoma

Interventions

RADIATION: 3-Dimensional Conformal Radiation Therapy
RADIATION: Intensity-Modulated Radiation Therapy (IMRT)
DRUG: Temozolomide
DRUG: Chloroquine
PROCEDURE: Tumor Treating Fields Therapy (TTF)

Sponsor

Barbara Ann Karmanos Cancer Institute